Thomas Seoh is CEO of Kinexum, a strategic advisory firm with deep expertise in regulatory, clinical and other translational matters in the development of life science products. He as previously held senior leadership positions in public and private, pharmaceutical, biotech and medical device companies for over 25 years. After practicing corporate law in New York and London and serving as General Counsel for several companies, he joined Guilford Pharmaceuticals in Baltimore, where he served as General Counsel, then head of Corporate and Commercial Development. He was then CEO of venture-backed Faust Pharmaceuticals in Strasbourg, France, and subsequently served in top leadership positions with emerging medical device companies in ex vivo liver dialysis device, mechanical thrombectomy and a plant-based skin scaffold for advanced wound care. He has also been a member of the Hopkins Alliance, an industry-faculty advisory board at Johns Hopkins School of Medicine. Thomas holds an AB in Philosophy and History and a JD from Harvard University.